AC Immune: Fourth Quarter Financial Results Overview

AC Immune SA Reports Fourth Quarter and Annual Financial Results

Based in Lausanne, Switzerland, AC Immune SA announced on Friday that it recorded a net loss of $18 million for the fourth quarter.

During this period, the company experienced a per-share loss of 18 cents.

The biopharmaceutical firm generated $423,000 in revenue for the quarter.

Looking at the full year, AC Immune SA's net loss expanded to $85 million, translating to a loss of 84 cents per share. Annual revenue reached $4.3 million.

At the close of trading, the company's stock was priced at $3, compared to $2.32 at the same time last year.